Cite
HARVARD Citation
Cortellini, A. et al. (2019). Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non‐small cell lung cancer patients: A "hypothesis‐generator" preliminary report. Thoracic cancer. 10 (2), pp. 347-351. [Online].